Trial · NCT02016183
Adverse events71
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 71
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hyperuricaemia | Metabolism and nutrition disorders | Candesartan Cilexetil/Hydrochlorothiazide | 81 | 3,157 | |
| other | Blood uric acid increased | Investigations | Candesartan Cilexetil/Hydrochlorothiazide | 77 | 3,157 | |
| serious | Bronchopneumonia | Infections and infestations | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Pharyngitis | Infections and infestations | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Pneumonia | Infections and infestations | Candesartan Cilexetil/Hydrochlorothiazide | 5 | 3,157 | |
| serious | Pyelonephritis acute | Infections and infestations | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Urinary tract infection | Infections and infestations | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Pneumonia bacterial | Infections and infestations | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Atypical mycobacterial infection | Infections and infestations | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Acute monocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Bile duct cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Breast cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 2 | 3,157 | |
| serious | Metastases to liver | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Pancreatic carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 | |
| serious | Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 3 | 3,157 | |
| serious | Metastases to central nervous system | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Candesartan Cilexetil/Hydrochlorothiazide | 1 | 3,157 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02016183/events